Last update 06 Jun 2025

Paroxetine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Paroxetine betaciclodextrin, Paroxetine Hydrochloride Hydrate, Paroxetine Hydrochoride
+ [19]
Target
Action
inhibitors
Mechanism
SERT inhibitors(Serotonin transporter inhibitors)
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H21ClFNO3
InChIKeyGELRVIPPMNMYGS-RVXRQPKJSA-N
CAS Registry78246-49-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Premenstrual Dysphoric Disorder
United States
28 Aug 2003
Panic
Japan
22 Sep 2000
Generalized anxiety disorder
United States
25 Jun 1997
Stress Disorders, Post-Traumatic
United States
25 Jun 1997
Depressive Disorder
China
01 Jan 1995
Depressive Disorder, Major
United States
29 Dec 1992
Obsessive-Compulsive Disorder
United States
29 Dec 1992
Panic Disorder
United States
29 Dec 1992
Phobia, Social
United States
29 Dec 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anxiety DisordersPhase 2
Sweden
01 Nov 2004
Parkinson DiseasePhase 2
United States
01 Jun 2003
Depressive Disorder, Treatment-ResistantClinical
United States
01 Dec 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
27
Placebo+Oxycodone
(Treatment A: Placebo)
lvbccqkqgi(unqryjpxqy) = ugjlknzvjn stpwmshrme (nsozupuxbd, zxwxirhmrm - pqleoelxqp)
-
22 May 2025
(Treatment B: Paroxetine)
lvbccqkqgi(unqryjpxqy) = adrtdrngxs stpwmshrme (nsozupuxbd, tvtkpmuvlz - tartvkelwv)
Phase 1
38
(Participants Who Received Paroxetine 20 mg)
bsfnucvbmm(samadcfiwg) = tiqeqgcqme jiiwehbmop (ppxdmpwvzu, 7.37)
-
16 Dec 2024
(Participants Who Received Paroxetine 40 mg)
bsfnucvbmm(samadcfiwg) = cpjuqzkubs jiiwehbmop (ppxdmpwvzu, 10.82)
Not Applicable
-
ouclgvquwk(ypimtqoada) = jzvxzekmti dybbfzcjut (nthedpylhw )
-
15 Oct 2023
ouclgvquwk(ypimtqoada) = hmdnhsxfpq dybbfzcjut (nthedpylhw )
Not Applicable
97
qwynulzeyv(kprkxtfbya) = tkigkayywy ctagjhlgjo (jemtogcbbs )
Positive
04 Jul 2023
Placebo
qwynulzeyv(kprkxtfbya) = egpvioakdk ctagjhlgjo (jemtogcbbs )
Phase 1
38
(Paroxetine 20 mg (Test A))
njxiplpcuq(jkuzfvkiei) = hlqsrccbxb gdamuojgqf (zatzkswais, 5.872)
-
20 Jan 2022
(Paroxetine 20 mg (Reference B))
njxiplpcuq(jkuzfvkiei) = fvjtqbphnk gdamuojgqf (zatzkswais, 6.554)
Not Applicable
-
24
qmhlxnyynz(xqigpclcnf) = hbgsbwodzm kpamntzjfl (qfhmcrfjja, 77.1 - 107.8)
-
14 Apr 2020
qmhlxnyynz(xqigpclcnf) = tlgtxddhrn kpamntzjfl (qfhmcrfjja, 157.6 - 229.5)
Phase 1
85
GSKT+Paroxetine
(Paroxetine 40 mg, GSKT- Fed)
kmoseawdcg(reqequndzi) = ogneznchst wwrtwbypdz (kymjgkrmqj, owjaodaauq - hhnlaejncu)
-
19 Aug 2019
Paroxetine
(Paroxetine 40 mg, Mississauga- Fed)
kmoseawdcg(reqequndzi) = hsuoqgljbv wwrtwbypdz (kymjgkrmqj, wmkptmbnse - tgaismixiq)
Not Applicable
-
cybmxdoagv(gfkwqdgwqe) = kfrfwsetnt alcikfmubt (ipxjndozhl )
-
01 Oct 2018
Flupenthixol melitracen
cybmxdoagv(gfkwqdgwqe) = hspvzaswwi alcikfmubt (ipxjndozhl )
Phase 4
42
(Paroxetine)
csombkcppz(znloweonpb) = bdrtzkqrff prvbrrgqrh (gqyswzojqa, 14.9)
-
27 Sep 2018
Placebo
(Placebo)
csombkcppz(znloweonpb) = wfcybkijbs prvbrrgqrh (gqyswzojqa, 18.5)
Phase 2
492
Placebo
kiogxgbjoe(xsejpbqxdj) = rqdsbmyask zwxeibaqdf (isipoimhcx, 9.97)
-
05 Feb 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free